Kenilworth, N.J. - Clarinex, a new systemic drug for treatmentof urticaria (hives), has been approved by the Food and Drug Administration(FDA), according to Schering-Plough, the drug's manufacturer.
Derm In The News: May 12-18
The Cutaneous Connection: A Reminder of Patient Impact
Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Dermatophytoma: A Diagnosis That You Do Not Want to Miss
QUIZ RECAP: Advanced Skin Cancer Awareness